George Frodsham

George Frodsham is the Founder and CEO of MediSieve Limited, a London-based biotech company he established in October 2014.12 MediSieve is developing an innovative medical device that uses magnetic blood filtration technology to remove specific substances from the blood without drugs or chemicals.2

Background and Education

George Frodsham has a strong academic background in science and engineering:

• He holds a Ph.D. in Biochemical Engineering from University College London (UCL)1
• He completed an MSc in Nanotechnology at UCL with distinction1
• He earned a BSc in Physics and Philosophy from King's College London with first-class honors1

Career Highlights

• Founder and CEO of MediSieve Limited (October 2014 - Present)1
• Enterprise Hub Member at the Royal Academy of Engineering (February 2015 - February 2016)1
• Enterprise Fellow at the Royal Society of Edinburgh (October 2014 - September 2015)1
• Writer for Bionews at Progress Educational Trust (September 2011 - July 2013)1

Achievements and Recognition

George Frodsham has received several accolades for his work:

• Winner of the Early Career Impact Award at the BBSRC Innovator of the Year Awards 20193
• Recognized as an 'Engineering Icon' by the Royal Academy of Engineering and Transport for London in 20233
• MediSieve won the Investment Achievement Award at the MedTech London Awards 20193

MediSieve's Technology

The device developed by Frodsham and his team at MediSieve aims to treat bloodborne diseases by filtering blood to remove specific infections.2 This technology has potential applications in treating conditions such as malaria, sepsis, and blood cancers.2

George Frodsham's journey from a student with a passion for building things to the CEO of a innovative medical technology company showcases his commitment to using engineering to improve healthcare and potentially save lives.2